Cel-Sci/$CVM
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Cel-Sci
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Ticker
$CVM
Sector
Primary listing
AMEX
Industry
Biotechnology
Headquarters
Employees
44
ISIN
US1508377066
Website
Cel-Sci Metrics
BasicAdvanced
$13M
-
-$12.33
0.26
-
Price and volume
Market cap
$13M
Beta
0.26
52-week high
$5.22
52-week low
$1.98
Financial strength
Current ratio
0.55
Quick ratio
0.351
Long term debt to equity
102.336
Total debt to equity
131.678
Interest coverage (TTM)
-36.54%
Profitability
EBITDA (TTM)
-23.937
Management effectiveness
Return on assets (TTM)
-62.86%
Return on equity (TTM)
-244.56%
Valuation
Price to book
0.89
Price to tangible book (TTM)
0.9
Price to free cash flow (TTM)
-0.31
Free cash flow yield (TTM)
-322.70%
Free cash flow per share (TTM)
-813.17%
Growth
Earnings per share change (TTM)
-34.35%
3-year earnings per share growth (CAGR)
-22.24%
10-year earnings per share growth (CAGR)
-27.91%
Cel-Sci News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cel-Sci stock?
Cel-Sci (CVM) has a market cap of $13M as of July 04, 2025.
What is the P/E ratio for Cel-Sci stock?
The price to earnings (P/E) ratio for Cel-Sci (CVM) stock is 0 as of July 04, 2025.
Does Cel-Sci stock pay dividends?
No, Cel-Sci (CVM) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Cel-Sci dividend payment date?
Cel-Sci (CVM) stock does not pay dividends to its shareholders.
What is the beta indicator for Cel-Sci?
Cel-Sci (CVM) has a beta rating of 0.26. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.